Abstract The biomedical field is beginning to explore the use of quantum machine learning (QML) for tasks traditionally handled by classical machine learning, especially in predicting ADME (absorption, distribution, metabolism, and excretion) properties, which are essential in drug evaluation. However, ADME tasks pose unique challenges for existing quantum computing systems (QCS) frameworks, as they involve both classification with unbalanced dataset and regression problems. These dual requirements make it necessary to adapt and refine current QCS frameworks to effectively address the complexities of ADME predictions.\\We propose a novel training-free scoring mechanism to evaluate QML circuit performance on imbalanced classification and regression tasks. Our mechanism demonstrates significant correlation between scoring metrics and test performance on imbalanced classification tasks. Additionally, we develop methods to quantify continuous similarity relationships between quantum states, enabling performance prediction for regression tasks. This represents the first comprehensive approach to searching and evaluating QCS circuits specifically for regression applications. \\Validation on representative ADME tasks—eight imbalanced classification and four regression—demonstrates moderate correlation between our scoring metrics and circuit performance, significantly outperforming baseline scoring methods that show negligible correlation.
Abstract The biomedical field is beginning to explore the use of quantum machine learning (QML) for tasks traditionally handled by classical machine learning, especially in predicting ADME (absorption, distribution, metabolism, and excretion) properties, which are essential in drug evaluation. However, ADME tasks pose unique challenges for existing quantum computing systems (QCS) frameworks, as they involve both classification with unbalanced dataset and regression problems. These dual requirements make it necessary to adapt and refine current QCS frameworks to effectively address the complexities of ADME predictions.\We propose a novel training-free scoring mechanism to evaluate QML circuit performance on imbalanced classification and regression tasks. Our mechanism demonstrates significant correlation between scoring metrics and test performance on imbalanced classification tasks. Additionally, we develop methods to quantify continuous similarity relationships between quantum states, enabling performance prediction for regression tasks. This represents the first comprehensive approach to searching and evaluating QCS circuits specifically for regression applications. \Validation on representative ADME tasks—eight imbalanced classification and four regression—demonstrates moderate correlation between our scoring metrics and circuit performance, significantly outperforming baseline scoring methods that show negligible correlation.
In the drug discovery paradigm, the evaluation of absorption, distribution, metabolism, and excretion (ADME) and toxicity properties of new chemical entities is one of the most critical issues, which is a time-consuming process, immensely expensive, and poses formidable challenges in pharmaceutical R&D. In recent years, emerging technologies like artificial intelligence (AI), big data, and cloud technologies have garnered great attention to predict the ADME and toxicity of molecules. Currently, the blend of quantum computation and machine learning has attracted considerable attention in almost every field ranging from chemistry to biomedicine and several engineering disciplines as well. Quantum computers have the potential to bring advances in high-throughput experimental techniques and in screening billions of molecules by reducing development costs and time associated with the drug discovery process. Motivated by the efficiency of quantum kernel methods, we proposed a quantum machine learning (QML) framework consisting of a classical support vector classifier algorithm with a kernel-based quantum classifier. To demonstrate the feasibility of the proposed QML framework, the simplified molecular input line entry system (SMILES) notation-based string kernel, combined with a quantum support vector classifier, is used for the evaluation of chemical/drug ADME-Tox properties. The proposed quantum machine learning framework is validated and assessed via large-scale simulations. Based on our results from numerical simulations, the quantum model achieved the best performance as compared to classical counterparts in terms of the area under the curve of the receiver operating characteristic curve (AUC ROC; 0.80-0.95) for predicting outcomes on ADME-Tox data sets for small molecules, with a different number of features. The deployment of the proposed framework in the pharmaceutical industry would be extremely valuable in making the best decisions possible.
The recent pandemic outbreak has posed significant challenges for medical research, particularly in drug discovery. Machine learning (ML) has become increasingly prevalent in various stages of drug discovery, aiming to support the advancement of new drug research while reducing time and cost investments. Furthermore, the emergence of quantum computing and quantum machine learning (QML) represents a significant advancement in this field, offering the ability to tackle the complex processes involved in drug discovery. This review provides a comprehensive perspective, comparing advanced QML to classical ML in drug discovery applications including drug design, virtual screening, and absorption, distribution, metabolism, excretion and toxicity (ADMET) prediction. Additionally, we summarize the current applications of QML algorithms to real-world datasets utilized in clinical research and drug discovery.
Classical computational approaches are steadily improving in their ability to predict molecular properties based on their sequences or structure, which is essential in drug discovery, irrespective of its many challenges. The major challenge is to use computational approaches to identify the properties, such as toxicity, solubility, etc. (ADMET), of the drug targets without costing much time. Machine learning and deep learning methods are employed for predicting ADMET properties. The proposed approach combines quantum computing with machine learning for the binary task of toxicity prediction based on the SMILES data. This Quantum Machine Learning (QML) approach involves a novel five-step procedure that converts SMILES to their respective molecular fingerprints, which are in turn dimensionally reduced, consequently forming four qubits. These qubits are inputs to the QML models, such as the Quantum SVC (QSVC), Variational Quantum Circuits (VQC), and Quantum AutoEncoders (QAE). The models are trained and optimized by using different optimizers and then evaluated based on the accuracy metric. The QAE model outperformed the remaining model by achieving an accuracy of 99%.
Bioinformatics is a field that requires Artificial Intelligence (AI) capabilities to analyze and process large datasets. One solution currently reported to handle the problems of high complexity in AI models is Quantum Machine Learning (QML). QML is a way to process large datasets more quickly and accurately by using the rules of quantum physics. This research evaluates the ability of two QML methods, Quantum Support Vector Classifier (QSVC) and Variational Quantum Circuit (VQC), to predict off-target effects in CRISPR/Cas9. The dataset used has a very high data imbalance, making it a challenge for the model to handle the imbalance. To achieve the best model performance, our research uses hyperparameter optimization to determine the optimal parameters for the number of qubits and circuit depth with linear entanglement and ZZFeatureMap. Our evaluation performance uses AUROC and PRAUC as the primary references, followed by accuracy and F1-score. The comparison results indicated that QSVC achieved the best performance with six qubits and two repetitions, having AUROC 0.861, PRAUC 0.821, accuracy 0.785, and F1-score 0.781. In comparison, VQC had AUROC 0.713, PRAUC 0.602, accuracy 0.725, and an F1-score of 0.727. The results indicate that QSVC with appropriate parameters can provide significant results for imbalanced data in the case study of predicting off-target effects of CRISPR/Cas9. Future research is expected to process more datasets with QML enhancement to handle a larger number of datasets using more optimal resource utilization, addressing the analytical needs in the field of bioinformatics.
Machine Learning (ML) has been widely applied across numerous domains due to its ability to automatically identify informative patterns from data for various tasks. The availability of large-scale data and advanced computational power enables the development of sophisticated models and training strategies, leading to state-of-the-art performance, but it also introduces substantial challenges. Quantum Computing (QC), which exploits quantum mechanisms for computation, has attracted growing attention and significant global investment as it may address these challenges. Consequently, Quantum Machine Learning (QML), the integration of these two fields, has received increasing interest, with a notable rise in related studies in recent years. We are motivated to review these existing contributions regarding quantum circuit-based learning models for classical data analysis and highlight the identified potentials and challenges of this technique. Specifically, we focus not only on QML models, both kernel-based and neural network-based, but also on recent explorations of their integration with classical machine learning layers within hybrid frameworks. Moreover, we examine both theoretical analysis and empirical findings to better understand their capabilities, and we also discuss the efforts on noise-resilient and hardware-efficient QML that could enhance its practicality under current hardware limitations. In addition, we cover several emerging paradigms for advanced quantum circuit design and highlight the adaptability of QML across representative application domains. This study aims to provide an overview of the contributions made to bridge quantum computing and machine learning, offering insights and guidance to support its future development and pave the way for broader adoption in the coming years.
Abstract Background Quantum machine learning (QML) is an emerging field that may offer unique advantages over classical machine learning but has not been extensively studied with real-world healthcare data of practical size. This study evaluates the performance of a recently proposed quantum machine learning algorithm—quantum circuits with data re-uploading (QC-REUP)—in comparison to classical machine learning and other QML methods. Performance was assessed using both benchmarking data sets and real-world laboratory medicine data. Methods Four data sets containing between 2 and 30 features were selected for evaluation. Initial baseline comparisons of classification performance (F1 score) were conducted using all algorithms—QC-REUP, 2 QML, and 4 classical machine learning (ML) algorithms—across the four data sets. Configuration parameters were then optimized for the QC-REUP algorithm using a previously published data set of plasma amino acid (PAA) profiles to determine the impact of optimization on classification performance, followed by a final comparison against classical ML algorithms. Results Baseline comparisons showed that QC-REUP outperformed quantum and linear classical algorithms on lower-dimensional data sets. However, as input dimensionality increased, QML F -score declined. Following optimization, QC-REUP improved relative to baseline, and again performed comparably to linear algorithms, but ultimately demonstrated lower performance than nonlinear classical ML algorithms on the PAA data set. Conclusion This study suggests that data re-uploading algorithms can perform comparably to classical approaches in specific contexts, particularly with low-dimensional data. While optimization can enhance performance, further improvements in quantum hardware and algorithmic development are likely needed before QML can be effectively applied in laboratory medicine and broader biomedical research.